. Author manuscript; available in PMC: 2021 Nov 1.

Published in final edited form as: Gastroenterol Nurs. 2020 Nov-Dec;43(6):429–439. doi: 10.1097/SGA.0000000000000483

Table 3.

Condition-specific factors and received social support

Variable	Received tangible social support
	Coeff. (95% CI)	P value
Medication types
Biologics (ref: no biologic)	5.4 (2.4, 8.5)	0.001
Immunomodulators (ref: no immunomodulator)	19.8 (17.6, 21.9)	0.000
Biologics x Immunomodulators	−19.0 (−24.6, −13.4)	0.000
Time since diagnosis (months)	0.02 (−0.003, 0.04)	0.088
Symptom interference	1.1 (−1.3, 3.5)	0.352
Constant	17.0 (15.2, 18.8)	0.000

Note: The following variables were centered at their means: time since diagnosis (mean: 76.3 months) and symptom interference (mean: 1.1).